ArticleJournal of clinical medicine2025

KRAS G12C Mutation Predicts Improved Survival in NSCLC Patients Receiving Immunotherapy: Insights from a Real-World Cohort.

Aslı Geçgel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.